Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Fuhr

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Drug Safety|May 5, 1998
Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevanceU Fuhr
Medizinische Klinik (Munich, Germany : 1983)|April 9, 1999
["Clinically significant" new drug interactions]U Fuhr
Clinical Pharmacokinetics|July 8, 2000
Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humansU Fuhr
International Journal of Clinical Pharmacology and Therapeutics|December 16, 1998
Tobacco smoking, alcohol, and special diet in drug trials: exclusion criteria or target of specific investigations?U Fuhr
Medizinische Klinik (Munich, Germany : 1983)|June 14, 2000
[Clinically significant" new drug interactions]U Fuhr
Current Drug Metabolism|April 3, 2010
Comparison of enzyme kinetic parameters obtained in vitro for reactions mediated by human CYP2C enzymes including major CYP2C9 variantsD Rokitta, U Fuhr
Pharmazie in Unserer Zeit|September 29, 2001
[Caution with methylxanthines, antacids or warfarin! Drug interactions with quinolones]A Jetter, U Fuhr
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2005
Individual variation in factors affecting the steps between dose application and effects of antineoplastic agentsU Fuhr, J Kirchheiner
Die Pharmazie|October 9, 2002
Rabeprazole: pharmacokinetics and pharmacokinetic drug interactionsU Fuhr, A Jetter
Pharmacogenetics|June 1, 1995
Availability of furafyllineU Fuhr, W Pfleiderer
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Drug Safety|May 5, 1998
Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevanceU Fuhr
Medizinische Klinik (Munich, Germany : 1983)|April 9, 1999
["Clinically significant" new drug interactions]U Fuhr
Clinical Pharmacokinetics|July 8, 2000
Induction of drug metabolising enzymes: pharmacokinetic and toxicological consequences in humansU Fuhr
International Journal of Clinical Pharmacology and Therapeutics|December 16, 1998
Tobacco smoking, alcohol, and special diet in drug trials: exclusion criteria or target of specific investigations?U Fuhr
Medizinische Klinik (Munich, Germany : 1983)|June 14, 2000
[Clinically significant" new drug interactions]U Fuhr
Current Drug Metabolism|April 3, 2010
Comparison of enzyme kinetic parameters obtained in vitro for reactions mediated by human CYP2C enzymes including major CYP2C9 variantsD Rokitta, U Fuhr
Pharmazie in Unserer Zeit|September 29, 2001
[Caution with methylxanthines, antacids or warfarin! Drug interactions with quinolones]A Jetter, U Fuhr
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2005
Individual variation in factors affecting the steps between dose application and effects of antineoplastic agentsU Fuhr, J Kirchheiner
Die Pharmazie|October 9, 2002
Rabeprazole: pharmacokinetics and pharmacokinetic drug interactionsU Fuhr, A Jetter
Pharmacogenetics|June 1, 1995
Availability of furafyllineU Fuhr, W Pfleiderer
Pageof 9